{
  "nctId": "NCT03098420",
  "briefTitle": "Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section",
  "officialTitle": "Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section: A Prospective Randomized Double-Blinded Clinical Study",
  "protocolDocument": {
    "nctId": "NCT03098420",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2016-07-22",
    "uploadDate": "2021-05-21T11:56",
    "size": 3564056,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03098420/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE2",
    "PHASE3"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 29,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-07",
    "completionDate": "2021-05-20",
    "primaryCompletionDate": "2021-05-20",
    "firstSubmitDate": "2017-03-13",
    "firstPostDate": "2017-03-31"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n1. Women undergoing cesarean section delivery.\n2. Patients classified as American Society of Anesthesiology (ASA) class II or III.\n\n   1. ASA II: mild systemic disease, pregnancy\n   2. ASA III: severe systemic disease\n3. Women â‰¥ 18 years old\n4. Neuraxial anesthesia (spinal) to be used as anesthetic technique intraoperatively for cesarean section (this is the UAB Anesthesiology standard of care).\n\nExclusion Criteria:\n\n1. Any patient not classified as an ASA I or II.\n2. General Anesthesia or neuraxial anesthesia with epidural used as anesthetic techniques for cesarean section.\n3. Allergy/intolerance to local anesthetic or steroids.\n4. Pre-existing neurological and/or anatomical deficit that would preclude regional block.\n5. Coexisting coagulopathy such as hemophilia or von Willebrand Disease\n6. BMI \\> 40.\n7. Emergency Cesarean Sections",
    "healthyVolunteers": true,
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Average Pain Score",
        "description": "Average pain score (VAS) 48 hrs postoperatively between the study group and the control. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. 0 represents no pain, whereas 10 represents unbearable pain.",
        "timeFrame": "48 hours postoperatively"
      }
    ],
    "secondary": [
      {
        "measure": "First Post-Operative Opioid Administration",
        "description": "Time until first dose post-operative opioid administration between the study group and the control",
        "timeFrame": "baseline to 48 hrs postoperatively"
      },
      {
        "measure": "Average Opioid Consumption",
        "description": "Average opioid consumption 48 hrs postoperatively between the study group and the control",
        "timeFrame": "from the time of delivery to 48hrs postoperatively"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "PHASE2",
        "PHASE3"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 59,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:30:59.501Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}